Idera Pharmaceuticals reported $-6371000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 2982M 513M
Aceto ACET:US -10931000 10.44M
Agenus AGEN:US $ -83.99M 29.59M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Biogen BIIB:US $ 814.2M 255M
Dynavax Technologies DVAX:US $ 4.47M 3.58M
Eli Lilly And LLY:US $ 1988.6M 80.6M
GlaxoSmithKline GSK:LN 1482M 225M
Idera Pharmaceuticals IDRA:US $ -6.37M 122.11M
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M